共 45 条
- [36] Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial (vol 1, pg 448, 2015) JAMA ONCOLOGY, 2015, 1 (04) : 544 - 544
- [37] Tumor-infiltrating lymphocytes and associations with pathological complete response and event-free survival in HER2-positive early-stage breast cancer treated with lapatinib and trastuzumab: a secondary analysis of the NeoALTTO trial (vol 1, pg 448, 2015) JAMA ONCOLOGY, 2019, 5 (01) : 122 - 122
- [38] Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial (vol 1,pg 448, 2015) JAMA ONCOLOGY, 2015, 1 (08) : 1172 - 1172
- [39] Substance Monograph for 1, 2, 5, 6, 9, 10-Hexabromocyclododecane (HBCDD) - HBM-Values for HBCDD in the Fat Content of the Mother's Milk or Blood Plasma Statement of Commission "Human Biomonitoring" of the Federal Environment Agency (vol 58, pg 889, 2015) BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2017, 60 (05) : 572 - 574